Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist
Patent No. EP2506844 (titled "Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist") was filed by Glaxo Group on Nov 29, 2010. The application was issued on Dec 20, 2017.
Patent Summary
Patent Family
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents
EP2506844
- Application Number
- EP10781527A
- Filing Date
- Nov 29, 2010
- Status
- Opposition Rejected
- Jun 7, 2024
- Publication Date
- Dec 20, 2017
- External Links
- Slate, Register , Google Patents